This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care, which accounted for 49% of consolidated revenue in 2019. The Kabi segment (19% of revenue) manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. At 26% of revenue, the Helios segment operates private hospitals in Germany, Spain, and Latin America. At 6% of revenue, Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.
Else-Kroener-Strasse 1, Bad Homburg v.d.H, 61352, DE
P/E Ratio Range
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.
What was Fresenius SE & Co. KGaA’s price range in the past 12 months?
Fresenius SE & Co. KGaA lowest stock price was €24.01 and its highest was €51.54 in the past 12 months.
What is Fresenius SE & Co. KGaA’s market cap?
Fresenius SE & Co. KGaA’s market cap is €25.32B.
What is Fresenius SE & Co. KGaA’s price target?
The average price target for Fresenius SE & Co. KGaA is €49.40. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is €57.00 ,the lowest forecast is €40.00. The average price target represents 8.80% Increase from the current price of €45.405.
What do analysts say about Fresenius SE & Co. KGaA?
Fresenius SE & Co. KGaA’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
When is Fresenius SE & Co. KGaA’s upcoming earnings report date?
Fresenius SE & Co. KGaA’s upcoming earnings report date is Jul 30, 2021 which is in 2 days.
How were Fresenius SE & Co. KGaA’s earnings last quarter?
Fresenius SE & Co. KGaA released its earnings results on May 06, 2021. The company reported €0.78 earnings per share for the quarter, beating the consensus estimate of €0.775 by €0.005.
Is Fresenius SE & Co. KGaA overvalued?
According to Wall Street analysts Fresenius SE & Co. KGaA’s price is currently Undervalued.
Does Fresenius SE & Co. KGaA pay dividends?
Fresenius SE & Co. KGaA pays a Notavailable dividend of €0.88 which represents an annual dividend yield of 1.92%. Fresenius SE & Co. KGaA’s last Notavailable dividend payment was on May 27, 2021. Fresenius SE & Co. KGaA’s upcoming ex-dividend date is May 25, 2021
What is Fresenius SE & Co. KGaA’s EPS estimate?
Fresenius SE & Co. KGaA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fresenius SE & Co. KGaA have?
Fresenius SE & Co. KGaA has 557,540,000 shares outstanding.
What happened to Fresenius SE & Co. KGaA’s price movement after its last earnings report?
Fresenius SE & Co. KGaA reported an EPS of €0.78 in its last earnings report, beating expectations of €0.775. Following the earnings report the stock price went up 0.69%.
Which hedge fund is a major shareholder of Fresenius SE & Co. KGaA?
Currently, no hedge funds are holding shares in GB:0OO9